NUTRA PHARMA CORP (NPHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 30K 60K 90K Q3 '21: 19.3K Q4 '21: 26K Q1 '22: 13.8K Q2 '22: 28.4K Q3 '22: 24.6K Q4 '22: 79K Q1 '23: 54.5K Q2 '23: 52.4K Q3 '23: 51.6K Q4 '23: 47K Q1 '24: 37.7K Q2 '24: 51.7K Q3 '24: 75K Q4 '24: 81.9K Q1 '25: 74K Q2 '25: 84.5K Q3 '25: 70.2K Q4 '25: 28.9K Q1 '26: 27.2K Q2 '26: 34.5K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 50K 100K 150K Q2 '21: 21.5K Q3 '21: 9.6K Q1 '22: 7.8K Q2 '22: 29.6K Q3 '22: 68.2K Q4 '22: 143.5K Q1 '23: 103.1K Q2 '23: 84.6K Q3 '23: 115K Q4 '23: 93.7K Q1 '24: 35.2K Q2 '24: 54.8K Q3 '24: 70.7K Q4 '24: 86.6K Q1 '25: 59.1K Q2 '25: 63.4K Q3 '25: 64.6K Q4 '25: 9.5K Q1 '26: 19K Q2 '26: 32.6K Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '21: -512.3K Q4 '21: -496.2K Q1 '22: -308.4K Q2 '22: -341.1K Q3 '22: -236.5K Q4 '22: -1M Q1 '23: -398.7K Q2 '23: -182.3K Q3 '23: -165.8K Q4 '23: -140.2K Q1 '24: -295.3K Q2 '24: -219.5K Q3 '24: -184.8K Q4 '24: -178.9K Q1 '25: -349.8K Q2 '25: -290.5K Q3 '25: -356.1K Q4 '25: -465.9K Q1 '26: -379.2K Q2 '26: -435.5K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-6M 0 6M 12M 18M Q3 '21: 15.4M Q4 '21: 2.1M Q1 '22: 5M Q2 '22: -645.8K Q3 '22: 577.2K Q4 '22: 3.2M Q1 '23: -592.6K Q2 '23: -279.2K Q3 '23: -278.5K Q4 '23: -243.1K Q1 '24: -426.9K Q2 '24: -367.1K Q3 '24: -260.7K Q4 '24: -230.9K Q1 '25: -1.4M Q2 '25: 369.6K Q3 '25: -523.5K Q4 '25: -488.5K Q1 '26: -459.7K Q2 '26: -3.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 30K 60K 90K Q3 '21: 9.6K Q4 '21: 17K Q1 '22: 14.4K Q2 '22: 60.8K Q3 '22: 41.1K Q4 '22: 46.6K Q1 '23: 51.9K Q2 '23: 80.3K Q3 '23: 24.8K Q4 '23: 20.5K Q1 '24: 22.5K Q2 '24: 18.6K Q3 '24: 23.8K Q4 '24: 19.9K Q1 '25: 46.3K Q2 '25: 58.7K Q3 '25: 34.1K Q4 '25: 66K Q1 '26: 29.2K Q2 '26: 25.3K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '21: -412.9K Q4 '21: -233.7K Q1 '22: -258.2K Q2 '22: -284.8K Q3 '22: -165.3K Q4 '22: -54K Q1 '23: -92.8K Q2 '23: -186.8K Q3 '23: -84.2K Q4 '23: -186.2K Q1 '24: -171.2K Q2 '24: -93.6K Q3 '24: 19.1K Q4 '24: -178.2K Q1 '25: -405K Q2 '25: -288.4K Q3 '25: -250.8K Q4 '25: -219.8K Q1 '26: -327.8K Q2 '26: -251.2K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q4 '12: -151.7K Q1 '13: -64.1K Q4 '14: -58.8K Q1 '15: -117.7K Q2 '15: -502.4K Q3 '15: -208.4K Q4 '15: -190.4K Q4 '16: -390.8K Q1 '21: -604.3K Q2 '21: -523.8K Q3 '21: -417.5K Q4 '21: -238K Q1 '22: -316.2K Q2 '22: -284.8K Q3 '22: -165.3K Q4 '22: -54K Q1 '25: -431.1K Q2 '25: -288.4K Q3 '25: -250.8K Q4 '25: -219.8K Q1 '13 Q2 '15 Q4 '16 Q3 '21 Q2 '22 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15B 30B 45B Q1 '20: 12.3B Q2 '20: 6.6B Q3 '20: 13.1B Q1 '21: 7.1B Q2 '21: 11.8B Q3 '21: 12.7B Q1 '22: 14.5B Q2 '22: 7.5B Q3 '22: 15.6B Q1 '23: 7.6B Q2 '23: 7.6B Q3 '23: 7.6B Q1 '24: 7.6B Q2 '24: 7.7B Q3 '24: 7.7B Q1 '25: 7.7B Q2 '25: 37.7B Q3 '25: 7.8B Q1 '26: 8B Q2 '26: 8.1B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.